xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT05978141</url>
    </required_header>
    <id_info>
      <org_study_id>23-190</org_study_id>
      <nct_id>NCT05978141</nct_id>
    </id_info>
    <brief_title>A Registry for People With T-cell Lymphoma</brief_title>
    <official_title>The T-cell Lymphoma Master Repository (TCLMR): A Prospective Databank of Patients With T-cell Lymphoma With Clinical Annotation and Matched Tumor Specimens</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>Memorial Sloan Kettering Cancer Center</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
    </sponsors>
    <source>Memorial Sloan Kettering Cancer Center</source>
    <oversight_info>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        The purpose of this registry study is to create a database-a collection of information-for&#xD;
        better understanding T-cell lymphoma. Researchers will use the information from this database&#xD;
        to learn more about how to improve outcomes for people with T-cell lymphoma.&#xD;
      </textblock>
    </brief_summary>
    <overall_status>Recruiting</overall_status>
    <start_date type="Actual">July 27, 2023</start_date>
    <completion_date type="Anticipated">July 27, 2030</completion_date>
    <primary_completion_date type="Anticipated">July 27, 2030</primary_completion_date>
    <study_type>Observational [Patient Registry]</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <observational_model>Cohort</observational_model>
      <time_perspective>Prospective</time_perspective>
    </study_design_info>
    <target_duration>10 Years</target_duration>
    <primary_outcome>
      <measure>Number of participants populating the T-cell Lymphoma Master Repository/TCLMR</measure>
      <time_frame>10 years</time_frame>
      <description>To develop and populate a secure database comprised of patients with T-cell lymphomas with curated clinical characteristics and treatment outcomes matched to pathological biospecimens.</description>
    </primary_outcome>
    <number_of_groups>1</number_of_groups>
    <enrollment type="Anticipated">1000</enrollment>
    <condition>T-cell Lymphoma</condition>
    <condition>NK-Cell Lymphoma</condition>
    <condition>T-cell Prolymphocytic Leukemia</condition>
    <condition>T-cell Large Granular Lymphocytic Leukemia</condition>
    <condition>Chronic Lymphoproliferative Disorder of NK Cells</condition>
    <condition>Aggressive NK-cell Leukemia</condition>
    <condition>Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder)</condition>
    <condition>Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood</condition>
    <condition>Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form</condition>
    <condition>Hydroa Vacciniforme-Like Lymphoproliferative Disorder</condition>
    <condition>Adult T-cell Leukemia/Lymphoma</condition>
    <condition>Extranodal NK/T-cell Lymphoma, Nasal Type</condition>
    <condition>Enteropathy-associated T-cell Lymphoma</condition>
    <condition>Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma</condition>
    <condition>Intestinal T-Cell Lymphoma, Not Otherwise Specified</condition>
    <condition>Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract</condition>
    <condition>Hepatosplenic T-cell Lymphoma</condition>
    <condition>Subcutaneous Panniculitis-Like T-Cell Lymphoma</condition>
    <condition>Mycosis Fungoides</condition>
    <condition>Sezary Syndrome</condition>
    <condition>Primary Cutaneous Anaplastic Large Cell Lymphoma</condition>
    <condition>Primary Cutaneous T-cell Lymphoma</condition>
    <condition>Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma</condition>
    <condition>Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma</condition>
    <condition>Peripheral T-Cell Lymphoma, Not Otherwise Specified</condition>
    <condition>Angioimmunoblastic T-cell Lymphoma</condition>
    <condition>Follicular T-Cell Lymphoma</condition>
    <condition>Nodal Peripheral T-Cell Lymphoma With TFH Phenotype</condition>
    <condition>Anaplastic Large Cell Lymphoma, ALK-Positive</condition>
    <condition>Anaplastic Large Cell Lymphoma, ALK-negative</condition>
    <condition>Breast Implant-Associated Anaplastic Large Cell Lymphoma</condition>
    <arm_group>
      <arm_group_label>Participants with T-Cell Lymphoma</arm_group_label>
      <description>Participants with pathologically-confirmed mature T- or natural killer (NK)-cell lymphoma</description>
    </arm_group>
    <intervention>
      <intervention_type>Other</intervention_type>
      <intervention_name>Optional Blood Sample</intervention_name>
      <description>Participants may provide optional research blood samples for biobanking and future use</description>
      <arm_group_label>Participants with T-Cell Lymphoma</arm_group_label>
    </intervention>
    <intervention>
      <intervention_type>Other</intervention_type>
      <intervention_name>Optional Nail Sample</intervention_name>
      <description>Participants may also provide optional research nail samples for biobanking and future use</description>
      <arm_group_label>Participants with T-Cell Lymphoma</arm_group_label>
    </intervention>
    <eligibility>
      <study_pop>
        <textblock>
          Participants at Memorial Sloan Kettering Cancer Center (MSKCC) will be recruited through&#xD;
          the Lymphoma service in the Department of Medicine and the Department of Pediatrics.&#xD;
          Participants will be recruited at the participating centers.&#xD;
        </textblock>
      </study_pop>
      <sampling_method>Non-Probability Sample</sampling_method>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  Written informed consent&#xD;
  &#xD;
            -  Adequate fresh or archival tumor biopsy or intent to obtain fresh tumor biopsy.&#xD;
  &#xD;
            -  Pathologically-confirmed mature T- or natural killer (NK)-cell lymphoma meeting one of&#xD;
               the following diagnostic criterion (based on WHO classification and NCCN guidelines):&#xD;
  &#xD;
                 -  T-cell prolymphocytic leukemia&#xD;
  &#xD;
                 -  T-cell large granular lymphocytic leukemia&#xD;
  &#xD;
                 -  Chronic lymphoproliferative disorder of NK cells&#xD;
  &#xD;
                 -  Aggressive NK-cell leukemia&#xD;
  &#xD;
                 -  Systemic Epstein-Barr virus (EBV)-positive T-cell lymphoma of childhood&#xD;
  &#xD;
                 -  Chronic active EBV infection of T- and NK-cell type, systemic form&#xD;
  &#xD;
                 -  Hydroa vacciniforme-like lymphoproliferative disorder&#xD;
  &#xD;
                 -  Adult T-cell leukemia/lymphoma&#xD;
  &#xD;
                 -  Extranodal NK/T-cell lymphoma, nasal type&#xD;
  &#xD;
                 -  Enteropathy-associated T-cell lymphoma&#xD;
  &#xD;
                 -  Monomorphic epitheliotropic intestinal T-cell lymphoma&#xD;
  &#xD;
                 -  Intestinal T-cell lymphoma, not otherwise specified (NOS)&#xD;
  &#xD;
                 -  Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract&#xD;
  &#xD;
                 -  Hepatosplenic T-cell lymphoma&#xD;
  &#xD;
                 -  Subcutaneous panniculitis-like T-cell lymphoma&#xD;
  &#xD;
                 -  Mycosis fungoides (limited to those with ≥ stage IB disease and those receiving&#xD;
                    active therapy)&#xD;
  &#xD;
                 -  Sézary syndrome&#xD;
  &#xD;
                 -  Primary cutaneous anaplastic large cell lymphoma (receiving systemic therapy)&#xD;
  &#xD;
                 -  Primary cutaneous Gamma-Delta T-cell lymphoma&#xD;
  &#xD;
                 -  Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma&#xD;
  &#xD;
                 -  Primary cutaneous acral CD8+ T-cell lymphoma (receiving systemic therapy)&#xD;
  &#xD;
                 -  Peripheral T-cell lymphoma, not otherwise specified&#xD;
  &#xD;
                 -  Angioimmunoblastic T-cell lymphoma&#xD;
  &#xD;
                 -  Follicular T-cell lymphoma&#xD;
  &#xD;
                 -  Nodal peripheral T-cell lymphoma with TFH phenotype&#xD;
  &#xD;
                 -  Anaplastic large cell lymphoma, ALK-positive&#xD;
  &#xD;
                 -  Anaplastic large cell lymphoma, ALK-negative&#xD;
  &#xD;
                 -  Breast-implant associated anaplastic large cell lymphoma.&#xD;
  &#xD;
            -  NOTE: Patients with diagnoses of mycosis fungoides, primary cutaneous anaplastic large&#xD;
               cell lymphoma, and/or primary cutaneous acral CD8+ T-cell lymphoma must be receiving&#xD;
               systemic therapy.&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            -  Patients with of mycosis fungoides, primary cutaneous anaplastic large cell lymphoma,&#xD;
               and/or primary cutaneous acral CD8+ T-cell lymphoma not receiving systemic therapy.&#xD;
  &#xD;
            -  Inability to collect prospective data, measure response, or perform adequate follow-up&#xD;
               assessments in the clinical judgment of the treating physician. NOTE: Repository&#xD;
               participation does not exclude participation in clinical trials, nor does existing&#xD;
               clinical trial participation exclude enrollment in the study herein outlined.&#xD;
        </textblock>
      </criteria>
      <gender>All</gender>
      <minimum_age>N/A</minimum_age>
      <maximum_age>N/A</maximum_age>
      <healthy_volunteers>No</healthy_volunteers>
    </eligibility>
    <overall_official>
      <last_name>Steven Horwitz, MD</last_name>
      <role>Principal Investigator</role>
      <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
    </overall_official>
    <overall_contact>
      <last_name>Steven Horwitz, MD</last_name>
      <phone>646-608-2680</phone>
      <email>horwitzs@MSKCC.ORG</email>
    </overall_contact>
    <overall_contact_backup>
      <last_name>Alison Moskowitz, MD</last_name>
      <phone>646-608-3726</phone>
      <email>moskowia@mskcc.org</email>
    </overall_contact_backup>
    <location>
      <facility>
        <name>City of Hope Cancer Center (Data collection only)</name>
        <address>
          <city>Duarte</city>
          <state>California</state>
          <zip>91010</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Jasmine Zain, MD</last_name>
        <phone>626-359-8111</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only)</name>
        <address>
          <city>San Diego</city>
          <state>California</state>
          <zip>92103</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Aaron Goodman, MD</last_name>
        <phone>858-822-6100</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>University of California San Francisco (Data collection only)</name>
        <address>
          <city>San Francisco</city>
          <state>California</state>
          <zip>94143</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Weiyun Ai, MD</last_name>
        <phone>415-353-2421</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Stanford University Medical Center (Data collection only)</name>
        <address>
          <city>Stanford</city>
          <state>California</state>
          <zip>94305-5408</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Michael Khodadoust, MD</last_name>
        <phone>650-725-5071</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>University of Colorado (Data Collection Only)</name>
        <address>
          <city>Aurora</city>
          <state>Colorado</state>
          <zip>80045</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Bradley Haverkos, MD</last_name>
        <phone>212-639-3983</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Yale University (Data Collection Only)</name>
        <address>
          <city>New Haven</city>
          <state>Connecticut</state>
          <zip>06511</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Francine Foss, MD</last_name>
        <phone>203-200-4363</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>University of Miami (Data Collection Only)</name>
        <address>
          <city>Miami</city>
          <state>Florida</state>
          <zip>33136</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Jonathan Schatz, MD</last_name>
        <phone>305-243-5302</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Moffitt Cancer Center (Data Collection Only)</name>
        <address>
          <city>Tampa</city>
          <state>Florida</state>
          <zip>33612</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Lubomir Sokol, MD, PhD</last_name>
        <phone>888-663-3488</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Emory University (Data Collection Only)</name>
        <address>
          <city>Atlanta</city>
          <state>Georgia</state>
          <zip>30322</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Pamela Allen, MD, MSc</last_name>
        <phone>404-778-0519</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Northwestern Medicine (Data Collection)</name>
        <address>
          <city>Chicago</city>
          <state>Illinois</state>
          <zip>60611</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Jaehyuk Choi, MD, PhD</last_name>
        <phone>312-695-8106</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Massachusetts General Hospital (Data Collection Only)</name>
        <address>
          <city>Boston</city>
          <state>Massachusetts</state>
          <zip>02114</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Salvia Jain, MD</last_name>
        <phone>857-392-4495</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Dana Farber Cancer Institute (Data Collection Only)</name>
        <address>
          <city>Boston</city>
          <state>Massachusetts</state>
          <zip>02115</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Eric D Jacobsen, MD</last_name>
        <phone>877-442-3324</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Mayo Clinic (Data Collection Only)</name>
        <address>
          <city>Rochester</city>
          <state>Minnesota</state>
          <zip>55905</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Nora Bennani, MD</last_name>
        <phone>507-284-2511</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Washington University (Data Collection Only)</name>
        <address>
          <city>Saint Louis</city>
          <state>Missouri</state>
          <zip>63110</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Neha Mehta-Shah, MD, MSCI</last_name>
        <phone>314-747-1171</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>University of Nebraska (Data collection only)</name>
        <address>
          <city>Omaha</city>
          <state>Nebraska</state>
          <zip>68198-7680</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Matthew Lunning, DO, FACP</last_name>
        <phone>402-559-4000</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Memorial Sloan Kettering at Basking Ridge (All protocol activities)</name>
        <address>
          <city>Basking Ridge</city>
          <state>New Jersey</state>
          <zip>07920</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Recruiting</status>
      <contact>
        <last_name>Steven Horwitz, MD</last_name>
        <phone>646-608-2680</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Memorial Sloan Kettering Monmouth (All protocol activities)</name>
        <address>
          <city>Middletown</city>
          <state>New Jersey</state>
          <zip>07748</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Recruiting</status>
      <contact>
        <last_name>Steven Horwitz, MD</last_name>
        <phone>646-608-2680</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities)</name>
        <address>
          <city>Commack</city>
          <state>New York</state>
          <zip>11725</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Recruiting</status>
      <contact>
        <last_name>Steven Horwitz, MD</last_name>
        <phone>646-608-2680</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Memorial Sloan Kettering Westchester (All protocol activities)</name>
        <address>
          <city>Harrison</city>
          <state>New York</state>
          <zip>10604</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Recruiting</status>
      <contact>
        <last_name>Steven Horwitz, MD</last_name>
        <phone>646-608-2680</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Weill Cornell Medical Center (Data Collection Only)</name>
        <address>
          <city>New York</city>
          <state>New York</state>
          <zip>10021</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Jia Ruan, MD, PhD</last_name>
        <phone>646-962-2064</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Memorial Sloan Kettering Cancer Center (All Protocol Activities)</name>
        <address>
          <city>New York</city>
          <state>New York</state>
          <zip>10065</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Recruiting</status>
      <contact>
        <last_name>Steven Horwitz, MD</last_name>
        <phone>646-608-2680</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Memorial Sloan Kettering Nassau (All protocol activities)</name>
        <address>
          <city>Uniondale</city>
          <state>New York</state>
          <zip>11553</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Recruiting</status>
      <contact>
        <last_name>Steven Horwitz, MD</last_name>
        <phone>646-608-2680</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Ohio State University (Data Collection Only)</name>
        <address>
          <city>Columbus</city>
          <state>Ohio</state>
          <zip>43210</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>John Reneau, MD, PhD</last_name>
        <phone>614-293-8000</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>University of Pennsylvania (Data Collection Only)</name>
        <address>
          <city>Philadelphia</city>
          <state>Pennsylvania</state>
          <zip>19104</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Stefan Barta, MD, MS, MRCPCUK</last_name>
        <phone>(215) 316-5151</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>Thomas Jefferson University Hospital (Data collection only)</name>
        <address>
          <city>Philadelphia</city>
          <state>Pennsylvania</state>
          <zip>19107</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Pierluigi Porcu, MD</last_name>
        <phone>215-955-8874</phone>
      </contact>
    </location>
    <location>
      <facility>
        <name>MD Anderson Cancer Center (Data Collection Only)</name>
        <address>
          <city>Houston</city>
          <state>Texas</state>
          <zip>77030</zip>
          <country>United States</country>
        </address>
      </facility>
      <status>Not yet recruiting</status>
      <contact>
        <last_name>Swami Iyer, MD</last_name>
        <phone>713-352-2952</phone>
      </contact>
    </location>
    <location_countries>
      <country>United States</country>
    </location_countries>
    <link>
      <url>http://www.mskcc.org</url>
      <description>Memorial Sloan Kettering Cancer Center</description>
    </link>
    <verification_date>September 2023</verification_date>
    <study_first_submitted>July 28, 2023</study_first_submitted>
    <study_first_submitted_qc>July 28, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">August 7, 2023</study_first_posted>
    <last_update_submitted>September 1, 2023</last_update_submitted>
    <last_update_submitted_qc>September 1, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">September 5, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Sponsor</responsible_party_type>
    </responsible_party>
    <keyword>23-190</keyword>
    <keyword>T-cell lymphoma</keyword>
    <keyword>Memorial Sloan Kettering Cancer Center</keyword>
    <keyword>T-cell Lymphoma Master Repository</keyword>
    <keyword>TCLMR</keyword>
    <condition_browse>
      <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
      <mesh_term>Mycoses</mesh_term>
      <mesh_term>Epstein-Barr Virus Infections</mesh_term>
      <mesh_term>Lymphoma</mesh_term>
      <mesh_term>Leukemia</mesh_term>
      <mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
      <mesh_term>Lymphoma, T-Cell</mesh_term>
      <mesh_term>Lymphoma, T-Cell, Peripheral</mesh_term>
      <mesh_term>Mycosis Fungoides</mesh_term>
      <mesh_term>Sezary Syndrome</mesh_term>
      <mesh_term>Leukemia, T-Cell</mesh_term>
      <mesh_term>Leukemia-Lymphoma, Adult T-Cell</mesh_term>
      <mesh_term>Lymphoma, Large-Cell, Anaplastic</mesh_term>
      <mesh_term>Lymphoma, T-Cell, Cutaneous</mesh_term>
      <mesh_term>Lymphoma, Extranodal NK-T-Cell</mesh_term>
      <mesh_term>Leukemia, Prolymphocytic</mesh_term>
      <mesh_term>Leukemia, Large Granular Lymphocytic</mesh_term>
      <mesh_term>Leukemia, Prolymphocytic, T-Cell</mesh_term>
      <mesh_term>Enteropathy-Associated T-Cell Lymphoma</mesh_term>
      <mesh_term>Lymphoma, Primary Cutaneous Anaplastic Large Cell</mesh_term>
      <mesh_term>Lymphoproliferative Disorders</mesh_term>
      <mesh_term>Immunoblastic Lymphadenopathy</mesh_term>
      <mesh_term>Panniculitis</mesh_term>
      <mesh_term>Hydroa Vacciniforme</mesh_term>
      <mesh_term>Aggression</mesh_term>
    </condition_browse>
    <patient_data>
      <sharing_ipd>Yes</sharing_ipd>
      <ipd_description>Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.</ipd_description>
    </patient_data>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT05978141
  org study id: 23-190
  nct id: NCT05978141
  lead sponsor: 
  is fda regulated drug: No
  is fda regulated device: No
  The purpose of this registry study is to create a database-a collection of information-for
        better understanding T-cell lymphoma. Researchers will use the information from this database
        to learn more about how to improve outcomes for people with T-cell lymphoma.
  observational model: Cohort
  time perspective: Prospective
  measure: Number of participants populating the T-cell Lymphoma Master Repository/TCLMR
  time frame: 10 years
  description: To develop and populate a secure database comprised of patients with T-cell lymphomas with curated clinical characteristics and treatment outcomes matched to pathological biospecimens.
  arm group label: Participants with T-Cell Lymphoma
  description: Participants with pathologically-confirmed mature T- or natural killer (NK)-cell lymphoma
  intervention type: Other
  intervention name: Optional Blood Sample
  description: Participants may provide optional research blood samples for biobanking and future use
  arm group label: Participants with T-Cell Lymphoma
  intervention type: Other
  intervention name: Optional Nail Sample
  description: Participants may also provide optional research nail samples for biobanking and future use
  arm group label: Participants with T-Cell Lymphoma
  study pop: 
  sampling method: Non-Probability Sample
  criteria: 
  gender: All
  minimum age: N/A
  maximum age: N/A
  healthy volunteers: No
  last name: Steven Horwitz, MD
  role: Principal Investigator
  affiliation: Memorial Sloan Kettering Cancer Center
  last name: Steven Horwitz, MD
  phone: 646-608-2680
  email: horwitzs@MSKCC.ORG
  last name: Alison Moskowitz, MD
  phone: 646-608-3726
  email: moskowia@mskcc.org
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Recruiting
  contact: 
  facility: 
  status: Recruiting
  contact: 
  facility: 
  status: Recruiting
  contact: 
  facility: 
  status: Recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Recruiting
  contact: 
  facility: 
  status: Recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  facility: 
  status: Not yet recruiting
  contact: 
  country: United States
  url: http://www.mskcc.org
  description: Memorial Sloan Kettering Cancer Center
  responsible party type: Sponsor
  mesh term: Mycoses
  mesh term: Epstein-Barr Virus Infections
  mesh term: Lymphoma
  mesh term: Leukemia
  mesh term: Lymphoma, Non-Hodgkin
  mesh term: Lymphoma, T-Cell
  mesh term: Lymphoma, T-Cell, Peripheral
  mesh term: Mycosis Fungoides
  mesh term: Sezary Syndrome
  mesh term: Leukemia, T-Cell
  mesh term: Leukemia-Lymphoma, Adult T-Cell
  mesh term: Lymphoma, Large-Cell, Anaplastic
  mesh term: Lymphoma, T-Cell, Cutaneous
  mesh term: Lymphoma, Extranodal NK-T-Cell
  mesh term: Leukemia, Prolymphocytic
  mesh term: Leukemia, Large Granular Lymphocytic
  mesh term: Leukemia, Prolymphocytic, T-Cell
  mesh term: Enteropathy-Associated T-Cell Lymphoma
  mesh term: Lymphoma, Primary Cutaneous Anaplastic Large Cell
  mesh term: Lymphoproliferative Disorders
  mesh term: Immunoblastic Lymphadenopathy
  mesh term: Panniculitis
  mesh term: Hydroa Vacciniforme
  mesh term: Aggression
  sharing ipd: Yes
  ipd description: Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.